All In MedTech

FDA Clearance Tracker · P890014-S003

HA-IGMK RIA ASSAY/ETI-HA-IGMK PLUS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 2, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P890014-S003
Device name
HA-IGMK RIA ASSAY/ETI-HA-IGMK PLUS
Applicant location
Stillwater, MN
Received
Oct 5, 2000
Decided
Feb 2, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P890014

Device type

Device class
Class II
Regulation
21 CFR 866.3310

Every decision under product code LOL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A CHANGE IN THE STORAGE CONDITIONS AND PURIFICATION PROCESS OF SOME COMPONENTS OF THE HA-IGMK RIA DEVICE, AND THE ETI-HA-IGMK PLUS DEVICE.

Source documents

Other decisions for DiaSorin, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.